Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs

Jose-Luis Sagripanti
doi: https://doi.org/10.1101/2020.12.06.20244780
Jose-Luis Sagripanti
1US Department of Defense Ringgold standard institution-US Army, US Army Combat Capabilities Development Command. Aberdeen Proving Ground, Maryland, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gripan889@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Early predictions by computer simulation of 7 billion infections and 40 million deaths by COVID-19 during 2020 alone if lock-downs and other confining measures were not enforced may have justified restrictive policies mandated by governments of 165 countries. A main objective of the present study was to determine differences between the infection and death rate in countries that established early, nation-wide curfews, state-at-home orders, or lock-downs versus countries that did not mandate lock-downs to deal with the COVID-19 crisis.

The analyzed epidemiological data indicates that lock-downs, and other confining measures had no effect on the chances of healthy individuals becoming infected with- or dying of SARS-CoV-2.

The highest incidence of COVID-19 infection progressed from countries in northern latitudes, where it was winter at the beginning of the pandemic, to countries in the southern hemisphere in July 21, 2020 were winter was starting. This trend reversed again during the last quarter of 2020. A considerable (4-fold) increase in COVID-19 infection rate is observed between fall and beginning of winter in countries in the southern hemisphere. This seasonal progression correlates with the variation in the germicidal solar flux received by these countries, suggesting that infectious virus in the environment plays a role in the evolution of COVID-19. In addition, hypotheses are presented that could explain the recurrent new spikes of COVID-19 as well as the mortality of SARS-Co V-2 observed in some developed countries higher than the mortality rate reported in several developing countries.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The author (Dr. Jose-Luis Sagripanti) is not associated to any industrial or commercial enterprise. The author is not associated to any political party, serving during 30 years under various governments with different political orientations. No economical or political issues were considered during the study presented here and the findings should not be construed as supporting or criticizing any party or particular government

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Department of Defense, US Army. RETIRED

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The epidemiological data employed in this study is freely available from the sources listed in References. Most reprint of the listed References can be downloaded from the world wide web. Those articles not freely available can be requested from the author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted December 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs
Jose-Luis Sagripanti
medRxiv 2020.12.06.20244780; doi: https://doi.org/10.1101/2020.12.06.20244780
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs
Jose-Luis Sagripanti
medRxiv 2020.12.06.20244780; doi: https://doi.org/10.1101/2020.12.06.20244780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (450)
  • Dentistry and Oral Medicine (82)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5248)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (755)
  • Geriatric Medicine (80)
  • Health Economics (212)
  • Health Informatics (696)
  • Health Policy (356)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5848)
  • Intensive Care and Critical Care Medicine (358)
  • Medical Education (103)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (762)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (476)
  • Ophthalmology (150)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (140)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (859)
  • Public and Global Health (2004)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (283)
  • Rheumatology (94)
  • Sexual and Reproductive Health (73)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)